Suprelorin

Country: European Union

Language: French

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

acétate de desloréline

Available from:

Virbac S.A.

ATC code:

QH01CA93

INN (International Name):

deslorelin acetate

Therapeutic group:

Dogs; Ferrets

Therapeutic area:

Hormones hypophysaires et hypothalamiques et analogues

Therapeutic indications:

Pour l'induction de l'infertilité temporaire chez des chiens mâles et des furets sains, entiers et sexuellement matures.

Product summary:

Revision: 13

Authorization status:

Autorisé

Authorization date:

2007-07-10

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Des informations à jour sur ce médicament à usage vétérinaire
sont disponibles sur le site web
d’information sur les médicaments à usage vétérinaire.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Des informations à jour sur ce médicament à usage vétérinaire
sont disponibles sur le site web
d’information sur les médicaments à usage vétérinaire.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 15-02-2024
Public Assessment Report Public Assessment Report Bulgarian 21-07-2013
Patient Information leaflet Patient Information leaflet Spanish 15-02-2024
Public Assessment Report Public Assessment Report Spanish 21-07-2013
Patient Information leaflet Patient Information leaflet Czech 15-02-2024
Public Assessment Report Public Assessment Report Czech 21-07-2013
Patient Information leaflet Patient Information leaflet Danish 15-02-2024
Public Assessment Report Public Assessment Report Danish 21-07-2013
Patient Information leaflet Patient Information leaflet German 15-02-2024
Public Assessment Report Public Assessment Report German 21-07-2013
Patient Information leaflet Patient Information leaflet Estonian 15-02-2024
Public Assessment Report Public Assessment Report Estonian 21-07-2013
Patient Information leaflet Patient Information leaflet Greek 15-02-2024
Public Assessment Report Public Assessment Report Greek 21-07-2013
Patient Information leaflet Patient Information leaflet English 15-02-2024
Public Assessment Report Public Assessment Report English 21-07-2013
Patient Information leaflet Patient Information leaflet Italian 15-02-2024
Public Assessment Report Public Assessment Report Italian 21-07-2013
Patient Information leaflet Patient Information leaflet Latvian 15-02-2024
Public Assessment Report Public Assessment Report Latvian 21-07-2013
Patient Information leaflet Patient Information leaflet Lithuanian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 15-02-2024
Public Assessment Report Public Assessment Report Lithuanian 21-07-2013
Patient Information leaflet Patient Information leaflet Hungarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 15-02-2024
Public Assessment Report Public Assessment Report Hungarian 21-07-2013
Patient Information leaflet Patient Information leaflet Maltese 15-02-2024
Public Assessment Report Public Assessment Report Maltese 21-07-2013
Patient Information leaflet Patient Information leaflet Dutch 15-02-2024
Public Assessment Report Public Assessment Report Dutch 21-07-2013
Patient Information leaflet Patient Information leaflet Polish 15-02-2024
Public Assessment Report Public Assessment Report Polish 21-07-2013
Patient Information leaflet Patient Information leaflet Portuguese 15-02-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 15-02-2024
Public Assessment Report Public Assessment Report Portuguese 21-07-2013
Patient Information leaflet Patient Information leaflet Romanian 15-02-2024
Public Assessment Report Public Assessment Report Romanian 21-07-2013
Patient Information leaflet Patient Information leaflet Slovak 15-02-2024
Public Assessment Report Public Assessment Report Slovak 21-07-2013
Patient Information leaflet Patient Information leaflet Slovenian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 15-02-2024
Public Assessment Report Public Assessment Report Slovenian 21-07-2013
Patient Information leaflet Patient Information leaflet Finnish 15-02-2024
Public Assessment Report Public Assessment Report Finnish 21-07-2013
Patient Information leaflet Patient Information leaflet Swedish 15-02-2024
Public Assessment Report Public Assessment Report Swedish 21-07-2013
Patient Information leaflet Patient Information leaflet Norwegian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 15-02-2024
Patient Information leaflet Patient Information leaflet Icelandic 15-02-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 15-02-2024
Patient Information leaflet Patient Information leaflet Croatian 15-02-2024

View documents history